Patents by Inventor Zhiming Ma
Zhiming Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12145886Abstract: The present disclosure provides a recycled powder concrete material for 3D printing construction and a preparation method therefor. The concrete material includes the following components by weight parts: cement: 1.0 part; recycled powder: 0.1-2.0 parts; recycled fine aggregate: 1.0-12.0 parts; nano titanium dioxide: 0.001-0.18 parts; high elastic modulus polyethylene fiber: 0.005-0.15 parts; redispersible latex powder: 0.002-0.1 parts; cellulose: 0.001-0.045 parts; activator: 0.01-0.30 parts; polycarboxylic acid water reducing agent: 0.005-0.2 parts; and water: 0.2-2.0 parts. According to the recycled powder concrete material for 3D printing construction, construction waste recycling powder technology is combined with 3D printing construction technology. The safety, applicability and durability of 3D printing recycled powder concrete material are further improved through the optimization of the recycled powder concrete formula.Type: GrantFiled: January 23, 2019Date of Patent: November 19, 2024Assignee: TONGJI UNIVERSITYInventors: Jianzhuang Xiao, Zhiming Ma, Zhenhua Duan, Jiangtao Yu, Tao Ding
-
Publication number: 20240039777Abstract: This application discloses a modulation method, a demodulation method, and a communication apparatus, and relates to the field of communication technologies. The communication apparatus may obtain information bit sequences, divide the information bit sequences into G groups, then separately encode each group of information bit sequences to obtain r encoded bit sequences, map the r encoded bit sequences into a modulation symbol sequence, and output the modulation symbol sequence. The modulation method provided in embodiments of this application may implement a flexible compromise between complexity and robustness, and has a wider range of application.Type: ApplicationFiled: October 13, 2023Publication date: February 1, 2024Inventors: Xianhao Meng, Xianbin Wang, Yongtang Shi, Guiying Yan, Zhiming Ma
-
Publication number: 20210261461Abstract: The present disclosure provides a recycled powder concrete material for 3D printing construction and a preparation method therefor. The concrete material includes the following components by weight parts: cement: 1.0 part; recycled powder: 0.1-2.0 parts; recycled fine aggregate: 1.0-12.0 parts; nano titanium dioxide: 0.001-0.18 parts; high elastic modulus polyethylene fiber: 0.005-0.15 parts; redispersible latex powder: 0.002-0.1 parts; cellulose: 0.001-0.045 parts; activator: 0.01-0.30 parts; polycarboxylic acid water reducing agent: 0.005-0.2 parts; and water: 0.2-2.0 parts. According to the recycled powder concrete material for 3D printing construction, construction waste recycling powder technology is combined with 3D printing construction technology. The safety, applicability and durability of 3D printing recycled powder concrete material are further improved through the optimization of the recycled powder concrete formula.Type: ApplicationFiled: January 23, 2019Publication date: August 26, 2021Applicant: TongJi UniversityInventors: Jianzhuang XIAO, Zhiming MA, Zhenhua DUAN, Jiangtao YU, Tao DING
-
Publication number: 20160193268Abstract: An extract of Andrographis particulata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysaccharides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.Type: ApplicationFiled: January 7, 2016Publication date: July 7, 2016Applicant: Nutrition Science Partners LimitedInventors: Jifeng DUAN, Zhiming MA, Xiaoqiang YAN, Weihan ZHANG, Tao WANG, Yu CAI
-
Publication number: 20140315846Abstract: An extract of Andrographis paniculata extract containing androgapholide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysaccharides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.Type: ApplicationFiled: July 1, 2014Publication date: October 23, 2014Inventors: Jifeng DUAN, Zhiming MA, Xiaoqiang YAN, Weihan ZHANG, Tao WANG, Yu CAI
-
Publication number: 20140004212Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographotide, neoandrographolide, polysacchorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.Type: ApplicationFiled: September 6, 2013Publication date: January 2, 2014Applicant: Nutrition Science Partners LimitedInventors: Jifeng DUAN, Zhiming MA, Xiaoqiang YAN, Weihan ZHANG, Tao WANG, Yu CAI
-
Patent number: 8557302Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysacchorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.Type: GrantFiled: November 4, 2008Date of Patent: October 15, 2013Assignee: Nutrition Science Partners LimitedInventors: Jifeng Duan, Zhiming Ma, Xiaoqiang Yan, Weihan Zhang, Tao Wang, Yu Cai
-
Patent number: 8557308Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysacchorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.Type: GrantFiled: September 11, 2012Date of Patent: October 15, 2013Assignee: Nutrition Science Partners LimitedInventors: Jifeng Duan, Zhiming Ma, Xiaoqiang Yan, Weihan Zhang, Tao Wang, Yu Cai
-
Publication number: 20130023493Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysacchorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.Type: ApplicationFiled: September 11, 2012Publication date: January 24, 2013Applicant: HUTCHISON MEDIPHARMA ENTERPRISES LIMITEDInventors: Jifeng Duan, Zhiming Ma, Xiaoqiang Yan, Weihan Zhang, Tao Wang, Yu Cai
-
Patent number: 7625945Abstract: This invention relates to a method of inhibiting the expression of TNF? or IL-1? with a compound of the following formula: wherein R1 and R2 are defined herein. It also relates to is a method of treating inflammatory bowel disease with such a compound.Type: GrantFiled: March 11, 2005Date of Patent: December 1, 2009Assignee: Hutchison MediPharma Enterprises Ltd.Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Ke Pan, Weihan Zhang, Jianrong Hong, Jeff Duan, Yu Cai
-
Publication number: 20090117210Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysacchorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.Type: ApplicationFiled: November 4, 2008Publication date: May 7, 2009Applicant: Hutchison MediPharma Enterprises LimitedInventors: Jifeng Duan, Zhiming Ma, Xiaoqiang Yan, Weihan Zhang, Tao Wang, Yu Cai
-
Publication number: 20090117209Abstract: An extract of Andrographis paniculata extract containing andrographolide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysacchlorides, and flavanoids. Also disclosed is a pharmaceutical composition containing such an extract and its use for treating inflammatory bowel disease.Type: ApplicationFiled: November 2, 2007Publication date: May 7, 2009Applicant: Hutchison Medipharma Enterprises LimitedInventors: Jifeng Duan, Zhiming Ma, Xiaoqiang Yan, Weihan Zhang, Tao Wang, Yu Cai
-
Patent number: 7341748Abstract: This invention relates to a method of inhibiting TNF? or IL-1? expression with an extract of Andrographis paniculata. The extract contains andrographolide, 14-deoxy-andrographolide, 14-deoxy-11,12-dehydrogen-andrographolide, and neoandrographolide.Type: GrantFiled: April 27, 2005Date of Patent: March 11, 2008Assignee: Hutchison MediPharma Enterprises LimitedInventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Weihan Zhang, Jifeng Duan, Yu Cai
-
Publication number: 20060246156Abstract: This invention relates to a method of inhibiting TNF? or IL-1? expression with an extract of Andrographis paniculata. The extract contains andrographolide, 14-deoxy-andrographolide, 14-deoxy-11,12-dehydrogen-andrographolide, and neoandrographolide.Type: ApplicationFiled: April 27, 2005Publication date: November 2, 2006Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Weihan Zhang, Jifeng Duan, Yu Cai
-
Publication number: 20050226943Abstract: Compositions containing a Sophora flavescens flavonoids extract or its active ingredients, Kurarinone, 2?-methoxy-Kurarinone, and Sophoraflavanone G are described. Also disclosed is a method of treating TNF? and IL-1? related diseases using such compositions.Type: ApplicationFiled: March 30, 2005Publication date: October 13, 2005Inventors: Xiaoqiang Yan, Yumin Cui, Tao Wang, Zhiming Ma, Ke Pan, Weihan Zhang, Weihui Huang, Jianrong Hong, Jeff Duan, Yu Cai
-
Publication number: 20050215628Abstract: This invention relates to a method of inhibiting the expression of TNF? or IL-1? with a compound of the following formula: wherein R1 and R2 are defined herein. It also relates to is a method of treating inflammatory bowel disease with such a compound.Type: ApplicationFiled: March 11, 2005Publication date: September 29, 2005Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Ke Pan, Weihan Zhang, Jianrong Hong, Jeff Duan, Yu Cai
-
Patent number: RE42718Abstract: This invention relates to a method of inhibiting TNF? or IL-1? expression with an extract of Andrographis paniculata. The extract contains andrographolide, 14-deoxy-andrographolide, 14-deoxy-11,12-dehydrogen-andrographolide, and neoandrographolide.Type: GrantFiled: March 4, 2010Date of Patent: September 20, 2011Assignee: Hutchison Medipharma Enterprises LimitedInventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Weihan Zhang, Jifeng Duan, Yu Cai
-
Patent number: RE43423Abstract: This invention relates to a method of inhibiting TNF? or IL-1? expression with an extract of Andrographis paniculata. The extract contains andrographolide, 14-deoxy-andrographolide, 14-deoxy-11,12-dehydrogen-andrographolide, and neoandrographolide.Type: GrantFiled: July 22, 2011Date of Patent: May 29, 2012Assignee: Hutchison MediPharma Enterprises LimitedInventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Weihan Zhang, Jifeng Duan, Yu Cai